{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:47:59Z","timestamp":1790365679881,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Grant-in-Aid from the Ministry of Health, Labour, and Welfare of Japan"},{"name":"Practical Research Project for Allergic Diseases and Immunology"},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bbmt.2017.11.029","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T01:19:25Z","timestamp":1512177565000},"page":"717-725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0573-6685","authenticated-orcid":false,"given":"Nobuyoshi","family":"Arima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junya","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshio","family":"Yabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Morishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuho","family":"Najima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiyasu","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiwa","family":"Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadakazu","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyuki","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuo","family":"Ichinohe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiko","family":"Atsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2017.11.029_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri3370","article-title":"Variable NK cell receptors and their MHC class I ligands in immunity, reproduction and human evolution","volume":"13","author":"Parham","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0020","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0025","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4049\/jimmunol.172.1.644","article-title":"Determinants of antileukemia effects of allogeneic NK cells","volume":"172","author":"Leung","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0030","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bbmt.2006.04.008","article-title":"KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy","volume":"12","author":"Hsu","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0035","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1182\/blood-2004-12-4825","article-title":"Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes","volume":"105","author":"Hsu","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0040","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1365-2249.2007.03360.x","article-title":"Impact of natural killer cell dose and donor killer-cell immunoglobulin-like receptor (KIR) genotype on outcome following human leucocyte antigen-identical haematopoietic stem cell transplantation","volume":"148","author":"Clausen","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0045","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1182\/blood-2007-01-065383","article-title":"Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT","volume":"109","author":"Miller","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0050","doi-asserted-by":"crossref","first-page":"3918","DOI":"10.4049\/jimmunol.178.6.3918","article-title":"Relevance of C1 and C2 epitopes for hemopoietic stem cell transplantation: role for sequential acquisition of HLA-C-specific inhibitory killer Ig-like receptor","volume":"178","author":"Fischer","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0055","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1084\/jem.184.3.913","article-title":"Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules","volume":"184","author":"Mandelboim","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0060","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.4049\/jimmunol.180.6.3969","article-title":"Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3","volume":"180","author":"Moesta","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0065","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.4049\/jimmunol.1001494","article-title":"Coevolution of killer cell Ig-like receptors with HLA-C to become the major variable regulators of human NK cells","volume":"185","author":"Older Aguilar","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0070","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.1301580","article-title":"Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2\/KIR2DS2 on KIR2D NK cell repertoire formation","volume":"191","author":"David","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0075","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1200\/JCO.2016.70.7059","article-title":"KIR3DL1\/HL A-B subtypes govern acute myelogenous leukemia relapse after hematopoietic cell transplantation","volume":"35","author":"Boudreau","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbmt.2015.09.029","article-title":"Influence of differently licensed KIR2DL1-positive natural killer cells in transplant recipients with acute leukemia: a Japanese National Registry Study","volume":"22","author":"Arima","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0085","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1102025","article-title":"Immunology. NK cells lose their inhibition","volume":"305","author":"Parham","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024927","article-title":"Human NK cells differ more in their KIR2DL1-dependent thresholds for HLA-Cw6-mediated inhibition than in their maximal killing capacity","volume":"6","author":"Almeida","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0095","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1399-0039.2006.00793.x","article-title":"KIR2DL1 allelic diversity: four new alleles characterized in a bone marrow transplant population and three families","volume":"69","author":"Hou","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0100","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imm.12684","article-title":"Deciphering the killer-cell immunoglobulin-like receptor system at super-resolution for natural killer and T-cell biology","volume":"150","author":"B\u00e9ziat","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2011.08823.x","article-title":"Use of NK cell activity in cure by transplant","volume":"155","author":"Leung","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.bbmt.2007.09.012","article-title":"Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation","volume":"14","author":"Yabe","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0115","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20051884","article-title":"Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function","volume":"203","author":"Yawata","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0120","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1200\/JCO.2012.47.4007","article-title":"Effect of donor KIR2DL1 allelic polymorphism on the outcome of pediatric allogeneic hematopoietic stem-cell transplantation","volume":"31","author":"Bari","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0125","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.4049\/jimmunol.1501358","article-title":"Polymorphic HLA-C receptors balance the functional characteristics of KIR haplotypes","volume":"195","author":"Hilton","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0130","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ng2077","article-title":"Global diversity and evidence for coevolution of KIR and HLA","volume":"39","author":"Single","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0135","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12185-015-1894-x","article-title":"Introduction of Transplant Registry Unified Management Program 2 (TRUMP2): scripts for TRUMP data analyses, part I (variables other than HLA-related data)","volume":"103","author":"Atsuta","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0140","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/bjh.12279","volume":"161","author":"Kanda","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12185-015-1907-9","article-title":"Scripts for TRUMP data analyses. Part II (HLA-related data): statistical analyses specific for hematopoietic stem cell transplantation","volume":"103","author":"Kanda","year":"2016","journal-title":"Int J Hematol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0150","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1182\/blood-2008-09-177055","article-title":"Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation","volume":"113","author":"Yu","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0155","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.bjc.6603913","article-title":"Inhibitory KIR-HLA receptor-ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma","volume":"97","author":"Leung","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0160","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.4049\/jimmunol.1402124","article-title":"KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia","volume":"194","author":"Marra","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0165","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJMoa1200503","article-title":"HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1","volume":"367","author":"Venstrom","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0170","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3324\/haematol.2014.118679","article-title":"Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes","volume":"100","author":"Hejazi","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0175","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1182\/blood-2016-05-713099","article-title":"KIR gene haplotype: an independent predictor of clinical outcome in MDS patients","volume":"128","author":"Stringaris","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1182\/asheducation-2004.1.337","article-title":"Immunotherapeutic approaches for hematologic malignancies","author":"Caligiuri","year":"2004","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0185","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbmt.2014.11.681","article-title":"Reconstitution of natural killer cells in HLA-matched HSCT after reduced-intensity conditioning: impact on clinical outcome","volume":"21","author":"Pical-Izard","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0190","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nm1688","article-title":"Prevention of acute and chronic allograft rejection with CD4+CD25+Foxp3+ regulatory T lymphocytes","volume":"14","author":"Joffre","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0195","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3390\/biomedicines5020013","article-title":"HLA-C KIR-ligands determine the impact of anti-thymocyte globulin (ATG) on graft-versus-host and graft-versus-leukemia effects following hematopoietic stem cell transplantation","volume":"5","author":"Clausen","year":"2017","journal-title":"Biomedicines"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0200","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.it.2009.09.002","article-title":"Neonatal immunity: faulty T-helpers and the shortcomings of dendritic cells","volume":"30","author":"Zaghouani","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0205","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1432-2277.2004.00047.x","article-title":"ATG induction therapy: long-term effects on Th1 but not on Th2 responses","volume":"18","author":"Weimer","year":"2005","journal-title":"Transpl Int"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0210","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bbmt.2016.09.028","article-title":"Recipient HLA-C haplotypes and microRNA 148a\/b binding sites have no impact on allogeneic hematopoietic cell transplantation outcomes","volume":"23","author":"Hoff","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2017.11.029_bib0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169512","article-title":"Impact of donor activating KIR genes on HSCT outcome in C1-ligand negative myeloid disease patients transplanted with unrelated donors: a retrospective study","volume":"12","author":"Neuchel","year":"2017","journal-title":"PLoS One"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117308765?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879117308765?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:02:01Z","timestamp":1761058921000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879117308765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1083879117308765"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.11.029","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homozygous HLA-C1 is Associated with Reduced Risk of Relapse after HLA-Matched Transplantation in Patients with Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2017.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}